4127.TWO
Price:
$67
Market Cap:
$3.07B
Tien Liang BioTech Co., Ltd., established in 1960 and headquartered in New Taipei City, Taiwan, is a pharmaceutical enterprise involved in the development, manufacturing, and global distribution of a diverse array of health and medicinal products. The company's offerings include traditional Chinese medicine (TCM) formulations, predominantly in pill form. These remedies address a broad spectrum of conditions, such as internal organ deficiencies (e.g., liver and kidney), various forms of musculoskeletal and neuropathic discomfort (including low back pain, joint pain, rheumatism, gout, and neuralgia), and common ailments like dizziness, digestive issues (constipation, hemorrhoids), respiratory ...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2007-12-31
Stock Exchange
TWO
Ticker
4127.TWO
According to Tien Liang BioTech Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -304.55. This represents a change of 978.28% compared to the average of -28.24 of the last 4 quarters.
The mean historical PE Ratio of Tien Liang BioTech Co., Ltd. over the last ten years is 9.77. The current -304.55 PE Ratio has changed -311716.91% with respect to the historical average. Over the past ten years (40 quarters), 4127.TWO's PE Ratio was at its highest in in the September 2024 quarter at 124.29. The PE Ratio was at its lowest in in the December 2025 quarter at -133.52.
Average
9.77
Median
11.89
Minimum
-138.38
Maximum
162.37
Discovering the peaks and valleys of Tien Liang BioTech Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 336.92%
Maximum Annual PE Ratio = 162.37
Minimum Annual Increase = -246.41%
Minimum Annual PE Ratio = -138.38
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -138.38 | -185.23% |
| 2024 | 162.37 | 336.92% |
| 2023 | 37.16 | 212.65% |
| 2022 | 11.89 | -18.21% |
| 2021 | 14.53 | -246.41% |
| 2020 | -9.93 | 7.59% |
The current PE Ratio of Tien Liang BioTech Co., Ltd. (4127.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
20.38
5-year avg
17.51
10-year avg
9.77
Tien Liang BioTech Co., Ltd.’s PE Ratio is less than Anxo Pharmaceutical Co., Ltd. (-27.88), less than Excelsior Biopharma Inc. (-5.57), less than Prince Pharmaceutical Co., Ltd. (11.53), less than Allied Biotech Corporation (21.87), less than Enimmune corporation (-7.36), less than DV Biomed Co., Ltd. (-84.98), less than NaviFUS Corp. (-8.10), less than Bioptik Technology Incorporation (17.88), less than Genetics Generation Advancement Corp. (66.16), less than Lagis Enterprise Co., Ltd. (19.06),
| Company | PE Ratio | Market cap |
|---|---|---|
| -27.88 | $946.06M | |
| -5.57 | $1.10B | |
| 11.53 | $1.12B | |
| 21.87 | $2.82B | |
| -7.36 | $1.21B | |
| -84.98 | $823.34M | |
| -8.10 | $1.20B | |
| 17.88 | $1.37B | |
| 66.16 | $1.07B | |
| 19.06 | $1.31B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tien Liang BioTech Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Tien Liang BioTech Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Tien Liang BioTech Co., Ltd.'s PE Ratio?
How is the PE Ratio calculated for Tien Liang BioTech Co., Ltd. (4127.TWO)?
What is the highest PE Ratio for Tien Liang BioTech Co., Ltd. (4127.TWO)?
What is the 3-year average PE Ratio for Tien Liang BioTech Co., Ltd. (4127.TWO)?
What is the 5-year average PE Ratio for Tien Liang BioTech Co., Ltd. (4127.TWO)?
How does the current PE Ratio for Tien Liang BioTech Co., Ltd. (4127.TWO) compare to its historical average?